Sabrina Islam, MD, MPH, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University, offered insight to Reuters Health about a study published in the journal BMJ examining patient-level data of antidiabetic medication rosiglitazone and its association with increased cardiovascular risks. Dr. Islam was not involved in the study. MD Alert picked up the Reuters Health article.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH